Tratamiento de las neoplasias neuroendocrinas con radionúclidos

28 / 43

• 69 patients G3 (Ki67>20%) SSTR NEN expressing (68Ga PET-TC)
• 22p PRRT + CT 47p PRRT
• 46 pNET 11 CUP 6 Midgut 3 Gastric 3 Rectal
Zhang J et al. J Nucl Med 2018
Median follow-up time 94 months